National Cancer Institute; Notice of Closed Meeting, 47148 [2014-18997]

Download as PDF 47148 Federal Register / Vol. 79, No. 155 / Tuesday, August 12, 2014 / Notices Report.’’ Prepared for Andrew Stivers, FDA/ CFSAN. Prepared by Muth, M., M. Ball, M. Coglaiti, and S. Karns. RTI Project Number 0211460.005. March, 2011. 2. Gendel, Steven M. ‘‘Food Allergen Petitions and Notifications,’’ Memorandum to File. August 8, 2011. MSC 7616, Bethesda, MD 20892, 301–402– 3938, lr228v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Cancer Control, National Institutes of Health, HHS) Dated: August 6, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014–18997 Filed 8–11–14; 8:45 am] [FR Doc. 2014–19004 Filed 8–11–14; 8:45 am] Dated: August 6, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4164–01–P [FR Doc. 2014–18991 Filed 8–11–14; 8:45 am] BILLING CODE 4140–01–P National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings National Institute of Mental Health; Notice of Meeting National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Mental Health Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Cancer Institute; Notice of Closed Meeting emcdonald on DSK67QTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Peer Review Meeting. Date: September 4, 2014. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Room 3130, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Roberta Binder, Ph.D., Scientific Review Officer, Scientific, Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, Room 3130, Bethesda, MD 20892–7616, 301–496–7966, rbinder@ niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel ‘‘NIAID Investigator Initiated Program Project Applications (P01).’’ Date: September 17, 2014. Time: 9:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3120, 6700B Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Lynn Rust, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, Name of Committee: National Cancer Institute Special Emphasis Panel; Retroviral Pathogenesis, Treatment and Prevention. Date: September 11, 2014. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review Officer, Research Technology and Contract Review, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W102, Bethesda, MD 20892–8329, 240–276– 6341, vollbergt@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Jkt 232001 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 17:45 Aug 11, 2014 BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Mar<15>2010 Dated: August 6, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Name of Committee: National Advisory Mental Health Council. Date: September 18, 2014. Open: 8:30 a.m. to 12:30 p.m. Agenda: Presentation of NIMH Director’s Report and discussion of NIMH program and policy issues. Place: National Institutes of Health (NIH), Neuroscience Center, Conference Rooms C/ D/E, 6001 Executive Boulevard, Rockville, MD 20852. Closed: 1:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, Conference Rooms C/ D/E, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Jane A. Steinberg, Ph.D., Director, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, Bethesda, MD 20892– 9609, 301–443–5047. E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 79, Number 155 (Tuesday, August 12, 2014)]
[Notices]
[Page 47148]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18997]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Retroviral Pathogenesis, Treatment and Prevention.
    Date: September 11, 2014.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-8329, 240-276-6341, 
vollbergt@mail.nih.gov.

    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: August 6, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-18997 Filed 8-11-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.